First Time Loading...

Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 71.5 CHF 0.28% Market Closed
Updated: May 16, 2024
Section:
 

Relative Value

The Relative Value of one GALE stock under the Base Case scenario is 107.16 CHF. Compared to the current market price of 71.5 CHF, Galenica AG is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GALE Relative Value
Base Case
107.16 CHF
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
30
vs Industry
69
Median 3Y
0.9
Median 5Y
0.9
Industry
2.4
Forward
0.9
More Details
12.5
P/E
P/E
Price to Earnings
12.5
vs History
96
vs Industry
38
Median 3Y
17.9
Median 5Y
18
Industry
23.9
Forward
19.9
More Details
15.8
P/OCF
P/OCF
Price to OCF
15.8
vs History
25
vs Industry
27
Median 3Y
15
Median 5Y
13.5
Industry
15.6
More Details
19.9
P/FCFE
P/FCFE
Price to FCFE
19.9
vs History
58
vs Industry
26
Median 3Y
20.9
Median 5Y
20.4
Industry
22.5
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
95
vs Industry
37
Median 3Y
2.8
Median 5Y
2.8
Industry
2.3
More Details
1.1
EV/S
EV/S
Enterprise Value to Sales
1.1
vs History
23
vs Industry
66
Median 3Y
1.1
Median 5Y
1
Industry
2.5
Forward
1
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
60
vs Industry
52
Median 3Y
4
Median 5Y
4
Industry
5.3
More Details
13.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.9
vs History
44
vs Industry
26
Median 3Y
13.4
Median 5Y
13.6
Industry
12.9
Forward
13.4
More Details
21.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.4
vs History
46
vs Industry
23
Median 3Y
20.3
Median 5Y
21.1
Industry
17.8
Forward
18.7
More Details
18.2
EV/OCF
EV/OCF
Enterprise Value to OCF
18.2
vs History
22
vs Industry
25
Median 3Y
16.4
Median 5Y
15.3
Industry
15.4
More Details
27.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.5
vs History
20
vs Industry
19
Median 3Y
23.1
Median 5Y
20.7
Industry
19.6
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
90
vs Industry
44
Median 3Y
1.8
Median 5Y
1.8
Industry
2
More Details

Multiples Across Competitors

GALE Competitors Multiples
Galenica AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Galenica AG
SIX:GALE
3.6B CHF 1 12.5 13.9 21.4
US
Mckesson Corp
NYSE:MCK
71.4B USD 0.2 23.8 15.9 18.4
US
Cencora Inc
NYSE:COR
44.2B USD 0.2 23.9 11.8 16.4
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
23.7B USD 0.1 42.9 8.8 11.7
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD 0.8 24.5 12.5 17.6
CN
Sinopharm Group Co Ltd
HKEX:1099
70.4B HKD 0.1 7.3 1.8 2.1
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
IT
Amplifon SpA
MIL:AMP
7.7B EUR 3.4 49.8 15.9 31.5
CN
Huadong Medicine Co Ltd
SZSE:000963
58.8B CNY 1.4 20 15.2 15.2
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
53B CNY 0.2 14.1 8.3 8.3

See Also

Summary
GALE intrinsic value, competitors valuation, and company profile.
DCF Valuation
GALE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GALE stock valuation using valuation multiples.
Wall Street Estimates
GALE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GALE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.